Results 181 to 190 of about 61,203 (243)

Recurrent Drug‐Induced Pneumothorax Associated With Lenvatinib: A Case Report

open access: yesRespirology Case Reports, Volume 13, Issue 5, May 2025.
We present a rare case of a patient with recurrent pneumothorax induced by lenvatinib, used for the treatment of thymic carcinoma. Clinicians should be aware of the potential adverse effects of lenvatinib in patients with pulmonary metastasis or pleural dissemination. ABSTRACT We present a patient with recurrent pneumothorax induced by lenvatinib, used
Ryo Torii   +5 more
wiley   +1 more source

Safety and Early Clinical Outcomes Following Repair of Very Large Hiatus Hernia in Octogenarians

open access: yesWorld Journal of Surgery, Volume 49, Issue 5, Page 1237-1245, May 2025.
Very large hiatus hernias are often symptomatic, impact quality of life, and are increasingly encountered in aging populations. Laparoscopic repair offers excellent clinical outcomes. However, surgeons can be reluctant to offer surgery to the elderly due to concerns about morbidity and mortality.
Mathew A. Amprayil   +4 more
wiley   +1 more source

The Respiratory Tract Microbiome and Human Health

open access: yesMicrobial Biotechnology, Volume 18, Issue 5, May 2025.
The respiratory tract microbiome (RTM) trains the immune system and protects against infections. Changes in the RTM are linked to various respiratory diseases. High‐throughput methodologies and computational biology can improve our understanding of the RTM, paving the way for new diagnostic tools, treatments and preventive strategies to improve ...
Patricia Fernández de Córdoba‐Ansón   +4 more
wiley   +1 more source

Survival Outcome of Thoraco‐Laparoscopic McKeown Esophagectomy Versus Endoscopic Submucosal Dissection for Early‐Stage Esophageal Squamous Cell Carcinoma: A Propensity Score‐Matched Analysis

open access: yesThoracic Cancer, Volume 16, Issue 9, May 2025.
A image summarizing the survival analysis of patients in the ESD group and the TLME group after propensity score matching. For clinical‐T1aN0 ESCC, endoscopic submucosal dissection (ESD) demonstrated superior overall survival (OS) with comparable safety to thoraco‐laparoscopic McKeown esophagectomy (TLME).
Ping Yuan   +10 more
wiley   +1 more source

Lung Transplantation From Donors With a History of Substance Use

open access: yesClinical Transplantation, Volume 39, Issue 5, May 2025.
ABSTRACT Background Substance use is common among lung transplant donors, but concerns persist about graft damage. Stimulant drugs such as cocaine and methamphetamine can induce pulmonary arterial hypertension, while smoked products such as cannabis and crack cocaine can produce airway and parenchymal diseases. We sought to characterize donor substance
David Li   +8 more
wiley   +1 more source

Disruption of Hepatic Sinusoidal Homeostasis Leads to Hepatopulmonary Syndrome

open access: yesJournal of Cellular and Molecular Medicine, Volume 29, Issue 9, May 2025.
ABSTRACT Hepatopulmonary syndrome (HPS) is a pulmonary vascular complication of liver disease and/or portal hypertension. HPS manifests as impaired gas exchange and hypoxemia due to intrapulmonary vascular dilatations and shunts. In response to primary liver disease, the abnormal adaptation of respiratory epithelial cells, pulmonary endothelial cells ...
Jiaxin Chen   +7 more
wiley   +1 more source

A Comprehensive Review of Interstitial Lung Abnormalities

open access: yesRespirology, Volume 30, Issue 5, Page 385-397, May 2025.
ABSTRACT Interstitial lung abnormalities (ILAs) represent radiological entities that comprise changes compatible with an interstitial process, occurring in individuals not suspected to have interstitial lung disease (ILD). The prevalence of ILAs ranges from 2.5% to 16.7% in lung cancer screening and population‐based cohorts. ILAs have consistently been
Yuben Moodley, John A. Mackintosh
wiley   +1 more source

Lung Function Course of Patients With Pulmonary Fibrosis After Initiation of Anti‐Fibrotic Treatment: Real‐World Data From the Dutch National Registry

open access: yesRespirology, Volume 30, Issue 5, Page 417-423, May 2025.
ABSTRACT Background and Objective Real‐world data on lung function course of patients with progressive pulmonary fibrosis (PPF) treated with anti‐fibrotic medication are limited. We evaluated forced vital capacity (FVC) decline in patients with PPF and idiopathic pulmonary fibrosis (IPF) who started anti‐fibrotic treatment.
Mark G. J. P. Platenburg   +20 more
wiley   +1 more source

Home - About - Disclaimer - Privacy